New year, new CEOs for Covid vac­cine mak­ers Cure­Vac and No­vavax

Two biotech com­pa­nies that have been on long jour­neys to push through Covid vac­cines are get­ting new CEOs this year.

Cure­Vac CEO Franz-Wern­er Haas is step­ping aside af­ter three years in the po­si­tion for a new chief who’s com­ing from Sanofi. Alexan­der Zehn­der will join Cure­Vac as CEO of the mR­NA biotech on April 1, leav­ing his cur­rent po­si­tion as glob­al head of on­col­o­gy at Sanofi. Ac­cord­ing to a Cure­Vac rep­re­sen­ta­tive, “it’s cur­rent­ly not planned” that Haas will re­main on the man­age­ment board af­ter step­ping down as CEO.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER